CELLECTA, INC. Receives Second Phase Contract from the National Cancer…

Cellecta received a Phase II SBIR contract from the National Cancer Institute to identify combinations of DNA damage and repair genes that are essential for cancer cells. There is great interest in...

(PRWeb October 23, 2012)

Read the full story at http://www.prweb.com/releases/20121023/cellecta-rnai-screening/prweb10043967.htm


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: